Loading...
•
Dec 31, 2021
ResMed Q2 2022 Earnings Report
ResMed's second-quarter results reflected continued strong performance, resulting in double-digit top-line revenue growth and solid growth in software-as-a-service business.
Key Takeaways
ResMed Inc. announced results for the quarter ended December 31, 2021. Revenue increased by 12% to $894.9 million, and diluted earnings per share were $1.37.
Revenue increased by 12% to $894.9 million; up 13% on a constant currency basis.
Diluted earnings per share of $1.37; non-GAAP diluted earnings per share of $1.47.
Income from operations increased 12%; non-GAAP operating profit up 5%.
Gross margin of 56.4%; non-GAAP gross margin contracted 230 bps to 57.6%.
ResMed
ResMed
ResMed Revenue by Geographic Location
Revenue by Geographic Location
U.S., Canada, and Latin America Revenue
CapyFin.comEurope, Asia, and other markets Revenue
CapyFin.com Forward Guidance
No specific forward guidance was provided in the press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income